Literature DB >> 34772780

Treatment Burden in People with Hypertension is Correlated with Patient Experience with Self-Management.

Elizabeth A Rogers1, Hani Abi2, Mark Linzer2, David T Eton2.   

Abstract

INTRODUCTION: New hypertension guidelines in the United States may require more people to take multiple medications or implement lifestyle changes. Increased treatment burden may be an unintended consequence and lead to worse health outcomes. Our study examined whether treatment burden is associated with factors related to self-management in those with hypertension.
METHODS: We conducted a cross-sectional mailed survey of patients from 2 medical centers in Minnesota. Participants with 2 or more medical conditions completed the Patient Experience with Treatment and Self-management (PETS), a validated treatment burden questionnaire, as well as measures of confidence in self-management ability, health literacy, health care-related financial difficulties, and perception of provider interpersonal skills. We used partial correlation analyses, controlling for age, sex, race, and education, to test relationships among study variables.
RESULTS: Of 254 respondents who had a diagnosis of hypertension, 54% were female, 74% were non-Hispanic White, and the mean age was 67 years. People with hypertension who reported having lower confidence in self-management ability, lower health literacy, more financial difficulties, and health care providers with poorer interpersonal skills reported higher treatment burden scores (PETS scales correlation magnitude range 0.09 to 0.62, P < .05 on all but 4). The strongest associations were observed for medical information and physical/mental exhaustion with self-management (correlation magnitudes from 0.25 to 0.54, P < .01). DISCUSSION: Hypertension treatment guideline stringent blood pressure criteria may lead to more interventions-medical or lifestyle-creating strains on populations already challenged by abstract disease self-management and at risk of experiencing disparities in cardiovascular health outcomes. © Copyright 2021 by the American Board of Family Medicine.

Entities:  

Keywords:  Cardiovascular Diseases; Chronic Disease; Cross-Sectional Studies; Disease Management; Hypertension; Minnesota; Patient-Reported Outcome Measures; Self-Management; Surveys and Questionnaires

Mesh:

Year:  2021        PMID: 34772780      PMCID: PMC9110114          DOI: 10.3122/jabfm.2021.06.210191

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  5 in total

Review 1.  Self-management education: history, definition, outcomes, and mechanisms.

Authors:  Kate R Lorig; Halsted Holman
Journal:  Ann Behav Med       Date:  2003-08

2.  Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients.

Authors:  Chandra Y Osborn; Sunil Kripalani; Kathryn M Goggins; Kenneth A Wallston
Journal:  J Health Care Poor Underserved       Date:  2017

3.  Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden.

Authors:  David T Eton; Kathleen J Yost; Jin-Shei Lai; Jennifer L Ridgeway; Jason S Egginton; Jordan K Rosedahl; Mark Linzer; Deborah H Boehm; Azra Thakur; Sara Poplau; Laura Odell; Victor M Montori; Carl R May; Roger T Anderson
Journal:  Qual Life Res       Date:  2016-08-26       Impact factor: 4.147

4.  Treatment burden as a predictor of self-management adherence within the primary care population.

Authors:  Nathanial Schreiner; Sarah DiGennaro; Carla Harwell; Christopher Burant; Barbara Daly; Sara Douglas
Journal:  Appl Nurs Res       Date:  2020-05-15       Impact factor: 2.257

5.  Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.

Authors:  Rohan Khera; Yuan Lu; Jiapeng Lu; Anshul Saxena; Khurram Nasir; Lixin Jiang; Harlan M Krumholz
Journal:  BMJ       Date:  2018-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.